Skip to content
EntityQ425887· pop 10· linked from 195 articles

doxofylline

Sign in to save

Also known as Maxivent, ABC 12/3, Doxophylline

Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative.

Key facts

Drug.PubChem
50942
Drug.UNII
MPM23GMO7Z
Drug.KEGG
D03898
Drug.ATC_suffix
DA11
Drug.verifiedrevid
444222727
Drug.IUPAC_name
7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione
Drug.image
Doxofylline.svg
Drug.image_class
skin-invert-image
Drug.width
175
Drug.image2
Doxofylline-3D-balls.png
Drug.image_class2
bg-transparent
Drug.width2
225
Drug.legal_status
Rx-only
Drug.routes_of_administration
By mouth
Drug.CAS_number
69975-86-6
Drug.ATC_prefix
R03
Drug.DrugBank
DB09273
Drug.ChemSpiderID
46175

via Wikipedia infobox

Wikidata facts

Mass
266.101505
Show 4 more facts
chemical formula
C₁₁H₁₄N₄O₄
World Health Organisation international non-proprietary name
doxofylline
canonical SMILES
CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3
Commons category
Doxofylline
Sources (2)

via Wikidata · CC0

~2 min read

Article

5 sections
Contents
  • Medical uses
  • Pharmacology
  • Names
  • References
  • Further reading

Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative.

==Medical uses== Doxophylline is used to treat chronic respiratory diseases such as asthma and COPD. in clinical studies, it appears to be equal in efficacy to theophylline but with significantly fewer side effects. In 2014, the US Food and Drug Administration (FDA) granted an orphan drug designation to doxofylline for the treatment of bronchiectasis following the submission of an application by Alitair Pharmaceuticals.

Available in 9 languages

via Wikidata sitelinks · CC0

Connections

Categories